Browsing by Sponsor/Funder Cancer Treatment & Research Trust
Showing results 1 to 6 of 6
| Issue Date | Title | Author(s) |
| 31-Jul-2020 | Clinical portrait of the SARS-Cov-2 epidemic in European cancer patients | Pinato, D; Zambelli, A; Aguilar-Company, J; Bower, M; Sng, C, et al |
| 27-Sep-2016 | Decreased glutathione biosynthesis contributes to EGFR T790M-driven erlotinib resistance in non-small cell lung cancer | Li, H; Stokes, W; Chater, E; Roy, R; De Bruin, E, et al |
| 10-Feb-2016 | miR-515-5p controls cancer cell migration through MARK4 regulation | Pardo, OE; Munro, CE; Castellano, L; Hu, Y; Mauri, F, et al |
| 14-Jul-2021 | Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer | Pardo, O; Chrysostomou, S; Roy, R; Prischi, F; Thamlikitkul, L, et al |
| Jan-2014 | Screening and identification of kinases involved in drug resistance in bladder cancer | Seckl, Michael; Pardo, Olivier; Mufti, Uwais Bashir; , et al |
| 2-Sep-2021 | Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective | Soosaipillai, G; Wu, A; Dettorre, GM; Diamantis, N; Chester, J, et al |